Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
1.255
-0.115 (-8.39%)
Oct 27, 2025, 1:56 PM EDT - Market open
Applied Therapeutics Market Cap
Applied Therapeutics has a market cap or net worth of $180.74 million as of October 27, 2025. Its market cap has decreased by -80.83% in one year.
Market Cap
180.74M
Enterprise Value
150.76M
1-Year Change
-80.83%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since May 14, 2019, Applied Therapeutics's market cap has increased from $160.29M to $180.74M, an increase of 12.75%. That is a compound annual growth rate of 1.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 197.30M | 98.04% |
| Dec 31, 2024 | 99.62M | -61.49% |
| Dec 29, 2023 | 258.72M | 608.33% |
| Dec 30, 2022 | 36.52M | -84.43% |
| Dec 31, 2021 | 234.63M | -52.60% |
| Dec 31, 2020 | 494.96M | -2.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.24B |
| Abbott Laboratories | 220.78B |